chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Burning sensation on the bottom of their feet; Body aches; Joint pain (elbows, knees, and ankles); Low grade fever; Could hardly walk; Both knees were swollen; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Could hardly walk), JOINT SWELLING (Both knees were swollen), BURNING SENSATION (Burning sensation on the bottom of their feet), MYALGIA (Body aches) and ARTHRALGIA (Joint pain (elbows, knees, and ankles)) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007D21A and 047C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Rheumatoid arthritis, Blood pressure high and Hypercholesteremia. Concomitant products included AMLODIPINE for Blood pressure high, PRAVASTATIN for Hypercholesteraemia, HYDROXYCHLOROQUINE for Rheumatoid arthritis, VITAMIN B12 NOS (VITAMIN B 12 [VITAMIN B12 NOS]), VITAMIN D [VITAMIN D NOS], VITAMIN K3 [MENADIONE] and FOLIC ACID for an unknown indication.   On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Jul-2021, the patient experienced GAIT DISTURBANCE (Could hardly walk), JOINT SWELLING (Both knees were swollen), MYALGIA (Body aches), ARTHRALGIA (Joint pain (elbows, knees, and ankles)) and PYREXIA (Low grade fever). On 20-Jul-2021, the patient experienced BURNING SENSATION (Burning sensation on the bottom of their feet). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 19-Jul-2021, JOINT SWELLING (Both knees were swollen) and PYREXIA (Low grade fever) had resolved. At the time of the report, GAIT DISTURBANCE (Could hardly walk), BURNING SENSATION (Burning sensation on the bottom of their feet), MYALGIA (Body aches) and ARTHRALGIA (Joint pain (elbows, knees, and ankles)) outcome was unknown.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Punctured vial stored for 20 hours; A patient was administered their first dose of the Moderna COVID-19 vaccine from a vial that had been punctured and stored for 20 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A patient was administered their first dose of the Moderna COVID-19 vaccine from a vial that had been punctured and stored for 20 hours) and PRODUCT STORAGE ERROR (Punctured vial stored for 20 hours) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (A patient was administered their first dose of the Moderna COVID-19 vaccine from a vial that had been punctured and stored for 20 hours). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Punctured vial stored for 20 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A patient was administered their first dose of the Moderna COVID-19 vaccine from a vial that had been punctured and stored for 20 hours) and PRODUCT STORAGE ERROR (Punctured vial stored for 20 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment medications were provided No  Concomitant medications were provided
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: How long does the symptoms last; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (How long does the symptoms last) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (How long does the symptoms last). At the time of the report, VACCINATION COMPLICATION (How long does the symptoms last) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were mentioned. No treatment details were reported.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea, Sinus disorder
Clinical narrative: cold-like symptoms; runny nose; body aches/pains; sinus drainage; sore throat; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold-like symptoms), RHINORRHOEA (runny nose), MYALGIA (body aches/pains), SINUS DISORDER (sinus drainage) and OROPHARYNGEAL PAIN (sore throat) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041B21A and 078C21A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.   On 19-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Jul-2021, the patient experienced NASOPHARYNGITIS (cold-like symptoms), RHINORRHOEA (runny nose), MYALGIA (body aches/pains), SINUS DISORDER (sinus drainage) and OROPHARYNGEAL PAIN (sore throat). At the time of the report, NASOPHARYNGITIS (cold-like symptoms), RHINORRHOEA (runny nose), MYALGIA (body aches/pains), SINUS DISORDER (sinus drainage) and OROPHARYNGEAL PAIN (sore throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-261589 (Patient Link).
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 year old Vaccinated with Moderna COVID-19 Vaccine; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old Vaccinated with Moderna COVID-19 Vaccine) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old Vaccinated with Moderna COVID-19 Vaccine). On 08-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old Vaccinated with Moderna COVID-19 Vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided by the reporter. Treatment information was not provided. Reporter reported that the patient never received a second dose.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Followup received on 21 Jul 2021 contains nonsignificant information.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Her arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Her arm was sore) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047T21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jul-2021, the patient experienced MYALGIA (Her arm was sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MYALGIA (Her arm was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drug details were reported.   This case was linked to MOD-2021-261610 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: patient has failed to come in within the 42 day window for the second dose.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient has failed to come in within the 42 day window for the second dose.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient has failed to come in within the 42 day window for the second dose.). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient has failed to come in within the 42 day window for the second dose.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported No treatment medication were reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Localized soreness in right arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Localized soreness in right arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20) for COVID-19 vaccination.     The patient's past medical history included Hives. Concurrent medical conditions included Hay fever, Pollen allergy (Runny nose, eyes sneezy), Type 2 diabetes mellitus since February 2001, Macular telangiectasia since 2017, Allergy to molds, Dust allergy and Allergic to cats. Concomitant products included LISINOPRIL, FUROSEMIDE, ALLOPURINOL and INSULIN DEGLUDEC, LIRAGLUTIDE (XULTOPHY) for Diabetes.    On 05-Feb-2021 at 9:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Localized soreness in right arm). At the time of the report, PAIN IN EXTREMITY (Localized soreness in right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.   This case was linked to MOD-2021-261624 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Follow up received included no new information.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Hypoacusis, Malaise, Sinus disorder
Clinical narrative: not feeling well; Lightheadedness; right arm where the injection site got swollen up to the top of her shoulder; Headache; problem in her sinuses; Hearing impaired; blurred vision; This spontaneous case was reported by a consumer and describes the occurrence of HYPOACUSIS (Hearing impaired), VISION BLURRED (blurred vision), MALAISE (not feeling well), SINUS DISORDER (problem in her sinuses) and DIZZINESS (Lightheadedness) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038C21A and 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Augmentin), Obesity, Hypertension, Thyroid gland swelling and Injury NOS since September 2008. Concomitant products included CHONDROITIN SULFATE, GLUCOSAMINE HYDROCHLORIDE, METHYLSULFONYLMETHANE (TRIFLEX SOFT CHEWS) for Aching joints, METOPROLOL and HYDROCHLOROTHIAZIDE for Hypertension, ASA for Prevention, MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, the patient experienced HYPOACUSIS (Hearing impaired), VISION BLURRED (blurred vision), SINUS DISORDER (problem in her sinuses), VACCINATION SITE SWELLING (right arm where the injection site got swollen up to the top of her shoulder) and HEADACHE (Headache). On an unknown date, the patient experienced MALAISE (not feeling well) and DIZZINESS (Lightheadedness). The patient was treated with DOXYCYCLINE HYDROCHLORIDE for Adverse event, at a dose of 100 mg; SALBUTAMOL (ALBUTEROL HFA) for Adverse event, at a dose of 90 mcg and METHYLPREDNISOLONE for Adverse event, at a dose of 1 dosage form. At the time of the report, HYPOACUSIS (Hearing impaired), VISION BLURRED (blurred vision), MALAISE (not feeling well), SINUS DISORDER (problem in her sinuses), DIZZINESS (Lightheadedness), VACCINATION SITE SWELLING (right arm where the injection site got swollen up to the top of her shoulder) and HEADACHE (Headache) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that patient's race information was black and patient had done CT scan. Also had a pending MRI of the head.  Patient was referred to ortho, endocrinology, neurology, ENT and gastroenterology departments. Imaging awaits- MRI brain, US, CT scan.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow up information received on 26-JUL-2021 contains patient medical historical, current conditions. Concomitant and treatment medications and new event updated, outcome of the events and also vaccination related information updated.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vision blurred
Clinical narrative: not feeling well; Lightheadedness; right arm where the injection site got swollen up to the top of her shoulder; Headache; problem in her sinuses; Hearing impaired; blurred vision; This spontaneous case was reported by a consumer and describes the occurrence of HYPOACUSIS (Hearing impaired), VISION BLURRED (blurred vision), MALAISE (not feeling well), SINUS DISORDER (problem in her sinuses) and DIZZINESS (Lightheadedness) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038C21A and 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Augmentin), Obesity, Hypertension, Thyroid gland swelling and Injury NOS since September 2008. Concomitant products included CHONDROITIN SULFATE, GLUCOSAMINE HYDROCHLORIDE, METHYLSULFONYLMETHANE (TRIFLEX SOFT CHEWS) for Aching joints, METOPROLOL and HYDROCHLOROTHIAZIDE for Hypertension, ASA for Prevention, MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, the patient experienced HYPOACUSIS (Hearing impaired), VISION BLURRED (blurred vision), SINUS DISORDER (problem in her sinuses), VACCINATION SITE SWELLING (right arm where the injection site got swollen up to the top of her shoulder) and HEADACHE (Headache). On an unknown date, the patient experienced MALAISE (not feeling well) and DIZZINESS (Lightheadedness). The patient was treated with DOXYCYCLINE HYDROCHLORIDE for Adverse event, at a dose of 100 mg; SALBUTAMOL (ALBUTEROL HFA) for Adverse event, at a dose of 90 mcg and METHYLPREDNISOLONE for Adverse event, at a dose of 1 dosage form. At the time of the report, HYPOACUSIS (Hearing impaired), VISION BLURRED (blurred vision), MALAISE (not feeling well), SINUS DISORDER (problem in her sinuses), DIZZINESS (Lightheadedness), VACCINATION SITE SWELLING (right arm where the injection site got swollen up to the top of her shoulder) and HEADACHE (Headache) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that patient's race information was black and patient had done CT scan. Also had a pending MRI of the head.  Patient was referred to ortho, endocrinology, neurology, ENT and gastroenterology departments. Imaging awaits- MRI brain, US, CT scan.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow up information received on 26-JUL-2021 contains patient medical historical, current conditions. Concomitant and treatment medications and new event updated, outcome of the events and also vaccination related information updated.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm after Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm after Moderna vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047T21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jul-2021, the patient experienced PAIN IN EXTREMITY (Sore arm after Moderna vaccine). At the time of the report, PAIN IN EXTREMITY (Sore arm after Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter. Treatment information was not provided. for mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessment.    This case was linked to MOD-2021-261602 (Patient Link).
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: a 13-year-old who received the Moderna vaccine 1st dose today 20Jul2021 on her right arm; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a 13-year-old who received the Moderna vaccine 1st dose today 20Jul2021 on her right arm) in a 13-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a 13-year-old who received the Moderna vaccine 1st dose today 20Jul2021 on her right arm). On 20-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a 13-year-old who received the Moderna vaccine 1st dose today 20Jul2021 on her right arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow-up received included no new significant information. Reporter information updated.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia
Clinical narrative: lost sense of  smell; lost sense of taste; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (lost sense of  smell) and AGEUSIA (lost sense of taste) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026021A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jul-2021, the patient experienced ANOSMIA (lost sense of  smell) and AGEUSIA (lost sense of taste). The patient was treated with PARACETAMOL (TYLENOL) in July 2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, ANOSMIA (lost sense of  smell) and AGEUSIA (lost sense of taste) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported by the reporter.  It was reported that after the first dose, the patient had some side effects like Covid symptoms.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Depression, Dysgeusia, Fatigue, Hearing disability
Clinical narrative: bad heart palpitations; numbness in the face; issues with hearing (coming and going)/hearing things that are not there; signs of psychosis; seeing illusions; seeing flashes of light in darkness; losing his appetite; tasting chemicals in my mouth; worsening my depression; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (bad heart palpitations), HYPOAESTHESIA (numbness in the face), HEARING DISABILITY (issues with hearing (coming and going)/hearing things that are not there), PSYCHOTIC DISORDER (signs of psychosis) and ILLUSION (seeing illusions) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression.    On 15-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jul-2021, the patient experienced PALPITATIONS (bad heart palpitations), HYPOAESTHESIA (numbness in the face), HEARING DISABILITY (issues with hearing (coming and going)/hearing things that are not there), PSYCHOTIC DISORDER (signs of psychosis), ILLUSION (seeing illusions), PHOTOPSIA (seeing flashes of light in darkness), DECREASED APPETITE (losing his appetite), DYSGEUSIA (tasting chemicals in my mouth), DEPRESSION (worsening my depression) and FATIGUE (fatigue). At the time of the report, PALPITATIONS (bad heart palpitations), HYPOAESTHESIA (numbness in the face), HEARING DISABILITY (issues with hearing (coming and going)/hearing things that are not there), PSYCHOTIC DISORDER (signs of psychosis), ILLUSION (seeing illusions), PHOTOPSIA (seeing flashes of light in darkness), DECREASED APPETITE (losing his appetite), DYSGEUSIA (tasting chemicals in my mouth), DEPRESSION (worsening my depression) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    No relevant concomitant medications were reported. No treatment information was provided.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Illusion, Palpitations, Photopsia, Psychotic disorder
Clinical narrative: bad heart palpitations; numbness in the face; issues with hearing (coming and going)/hearing things that are not there; signs of psychosis; seeing illusions; seeing flashes of light in darkness; losing his appetite; tasting chemicals in my mouth; worsening my depression; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (bad heart palpitations), HYPOAESTHESIA (numbness in the face), HEARING DISABILITY (issues with hearing (coming and going)/hearing things that are not there), PSYCHOTIC DISORDER (signs of psychosis) and ILLUSION (seeing illusions) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression.    On 15-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jul-2021, the patient experienced PALPITATIONS (bad heart palpitations), HYPOAESTHESIA (numbness in the face), HEARING DISABILITY (issues with hearing (coming and going)/hearing things that are not there), PSYCHOTIC DISORDER (signs of psychosis), ILLUSION (seeing illusions), PHOTOPSIA (seeing flashes of light in darkness), DECREASED APPETITE (losing his appetite), DYSGEUSIA (tasting chemicals in my mouth), DEPRESSION (worsening my depression) and FATIGUE (fatigue). At the time of the report, PALPITATIONS (bad heart palpitations), HYPOAESTHESIA (numbness in the face), HEARING DISABILITY (issues with hearing (coming and going)/hearing things that are not there), PSYCHOTIC DISORDER (signs of psychosis), ILLUSION (seeing illusions), PHOTOPSIA (seeing flashes of light in darkness), DECREASED APPETITE (losing his appetite), DYSGEUSIA (tasting chemicals in my mouth), DEPRESSION (worsening my depression) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea
Clinical narrative: serious coughing spell; couldn't catch her breath; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (serious coughing spell) and DYSPNOEA (couldn't catch her breath) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (serious coughing spell) and DYSPNOEA (couldn't catch her breath). At the time of the report, COUGH (serious coughing spell) and DYSPNOEA (couldn't catch her breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was sent for an X-ray. Concomitant product information was not provided. Treatment information was not provided by the reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Additional information received and contains non significant information
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Pyrexia, SARS-CoV-2 test
Clinical narrative: Tested positive for COVID-19 after 1st dose; Fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19 after 1st dose) and PYREXIA (Fever) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included FISH OIL and TADALAFIL for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for COVID-19 after 1st dose) and PYREXIA (Fever). At the time of the report, COVID-19 (Tested positive for COVID-19 after 1st dose) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported ginkgo  as concomitant medication product No treatment medication was reported Patient preferred follow-up method via email   This case was linked to MOD-2021-261633 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Blood glucose, Dizziness, Fatigue, Heart rate
Clinical narrative: had my first episode of dizziness,20 minutes later I had a second episode of dizziness; loss of balance/complete loss of balance; Bp was 105/55; tired; soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (had my first episode of dizziness,20 minutes later I had a second episode of dizziness), BALANCE DISORDER (loss of balance/complete loss of balance), HYPOTENSION (Bp was 105/55), FATIGUE (tired) and MYALGIA (soreness in arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20) for COVID-19 vaccination.     The patient's past medical history included Hives and Hay fever. Concurrent medical conditions included Pollen allergy (Runny nose, eyes sneezy) since 20-Jan-1957, Allergy to molds, Dust allergy, Type 2 diabetes mellitus since February 2001 and Macular telangiectasia since March 2017. Concomitant products included LISINOPRIL for Diabetes, FUROSEMIDE, ALLOPURINOL and INSULIN DEGLUDEC, LIRAGLUTIDE (XULTOPHY) for an unknown indication.   On 03-Mar-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-May-2021 at 9:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (had my first episode of dizziness,20 minutes later I had a second episode of dizziness), BALANCE DISORDER (loss of balance/complete loss of balance), HYPOTENSION (Bp was 105/55), FATIGUE (tired) and MYALGIA (soreness in arm). At the time of the report, DIZZINESS (had my last episode of dizziness,20 minutes later I had a last episode of dizziness), BALANCE DISORDER (loss of balance/complete loss of balance), HYPOTENSION (Bp was 105/55), FATIGUE (tired) and MYALGIA (soreness in arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: 188 (High) elevated sugar level 188. normal level is 139 to 110 and 181 (High) two hours later 181. On an unknown date, Heart rate: 62 (normal) pulse 62. On an unknown date, Oxygen saturation: 95 (normal) oxygen 95.         No treatment information was reported.   This case was linked to MOD-2021-261608 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Myalgia, Oxygen saturation
Clinical narrative: had my first episode of dizziness,20 minutes later I had a second episode of dizziness; loss of balance/complete loss of balance; Bp was 105/55; tired; soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (had my first episode of dizziness,20 minutes later I had a second episode of dizziness), BALANCE DISORDER (loss of balance/complete loss of balance), HYPOTENSION (Bp was 105/55), FATIGUE (tired) and MYALGIA (soreness in arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20) for COVID-19 vaccination.     The patient's past medical history included Hives and Hay fever. Concurrent medical conditions included Pollen allergy (Runny nose, eyes sneezy) since 20-Jan-1957, Allergy to molds, Dust allergy, Type 2 diabetes mellitus since February 2001 and Macular telangiectasia since March 2017. Concomitant products included LISINOPRIL for Diabetes, FUROSEMIDE, ALLOPURINOL and INSULIN DEGLUDEC, LIRAGLUTIDE (XULTOPHY) for an unknown indication.   On 03-Mar-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-May-2021 at 9:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (had my first episode of dizziness,20 minutes later I had a second episode of dizziness), BALANCE DISORDER (loss of balance/complete loss of balance), HYPOTENSION (Bp was 105/55), FATIGUE (tired) and MYALGIA (soreness in arm). At the time of the report, DIZZINESS (had my last episode of dizziness,20 minutes later I had a last episode of dizziness), BALANCE DISORDER (loss of balance/complete loss of balance), HYPOTENSION (Bp was 105/55), FATIGUE (tired) and MYALGIA (soreness in arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: 188 (High) elevated sugar level 188. normal level is 139 to 110 and 181 (High) two hours later 181. On an unknown date, Heart rate: 62 (normal) pulse 62. On an unknown date, Oxygen saturation: 95 (normal) oxygen 95.         No treatment information was reported.   This case was linked to MOD-2021-261608 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis, Hepatomegaly, Kidney enlargement, Product dose omission issue
Clinical narrative: Swollen liver; Swollen kidney; She did not receive the 2nd dose between day 25-35 of getting the 1st dose; Bronchitis; This spontaneous case was reported by an other health care professional and describes the occurrence of BRONCHITIS (Bronchitis), HEPATOMEGALY (Swollen liver), KIDNEY ENLARGEMENT (Swollen kidney) and PRODUCT DOSE OMISSION ISSUE (She did not receive the 2nd dose between day 25-35 of getting the 1st dose) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced BRONCHITIS (Bronchitis). On an unknown date, the patient experienced HEPATOMEGALY (Swollen liver), KIDNEY ENLARGEMENT (Swollen kidney) and PRODUCT DOSE OMISSION ISSUE (She did not receive the 2nd dose between day 25-35 of getting the 1st dose). At the time of the report, BRONCHITIS (Bronchitis), HEPATOMEGALY (Swollen liver), KIDNEY ENLARGEMENT (Swollen kidney) and PRODUCT DOSE OMISSION ISSUE (She did not receive the 2nd dose between day 25-35 of getting the 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient's doctor recommended not to get second dose until all the symptoms subside. Patient has taken an ultrasound for swollen liver and kidney whose results were not reported. No concomitant product was reported. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pyrexia
Clinical narrative: Pain on their knees; Fever; Body aches; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain on their knees), PYREXIA (Fever) and MYALGIA (Body aches) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Pain on their knees), PYREXIA (Fever) and MYALGIA (Body aches). At the time of the report, ARTHRALGIA (Pain on their knees), PYREXIA (Fever) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Feeling hot, Inappropriate schedule of product administration, Myalgia, Pain in extremity
Clinical narrative: health care provider told the patient to wait 90 days before getting the second dose; Lower back pain; feeling warm; Soreness in right arm; Body aches; Fever (feeling warm); This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (health care provider told the patient to wait 90 days before getting the second dose), BACK PAIN (Lower back pain), FEELING HOT (feeling warm), PAIN IN EXTREMITY (Soreness in right arm) and MYALGIA (Body aches) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included FISH OIL, GINKGO BILOBA LEAF (GINKGO 100) and TADALAFIL for an unknown indication.   On 19-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jul-2021, the patient experienced BACK PAIN (Lower back pain), FEELING HOT (feeling warm), PAIN IN EXTREMITY (Soreness in right arm), MYALGIA (Body aches) and PYREXIA (Fever (feeling warm)). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (health care provider told the patient to wait 90 days before getting the second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (health care provider told the patient to wait 90 days before getting the second dose) had resolved and BACK PAIN (Lower back pain), FEELING HOT (feeling warm), PAIN IN EXTREMITY (Soreness in right arm), MYALGIA (Body aches) and PYREXIA (Fever (feeling warm)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: other (Positive) The patient tested positive for COVID-19 after 5 days of 1st dose.         No treatment information was provided   This case was linked to MOD-2021-261623 (Patient Link).
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: health care provider told the patient to wait 90 days before getting the second dose; Lower back pain; feeling warm; Soreness in right arm; Body aches; Fever (feeling warm); This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (health care provider told the patient to wait 90 days before getting the second dose), BACK PAIN (Lower back pain), FEELING HOT (feeling warm), PAIN IN EXTREMITY (Soreness in right arm) and MYALGIA (Body aches) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included FISH OIL, GINKGO BILOBA LEAF (GINKGO 100) and TADALAFIL for an unknown indication.   On 19-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jul-2021, the patient experienced BACK PAIN (Lower back pain), FEELING HOT (feeling warm), PAIN IN EXTREMITY (Soreness in right arm), MYALGIA (Body aches) and PYREXIA (Fever (feeling warm)). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (health care provider told the patient to wait 90 days before getting the second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (health care provider told the patient to wait 90 days before getting the second dose) had resolved and BACK PAIN (Lower back pain), FEELING HOT (feeling warm), PAIN IN EXTREMITY (Soreness in right arm), MYALGIA (Body aches) and PYREXIA (Fever (feeling warm)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: other (Positive) The patient tested positive for COVID-19 after 5 days of 1st dose.         No treatment information was provided   This case was linked to MOD-2021-261623 (Patient Link).
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vaccination complication, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Left arm warm to the touch; Little golf ball appeared in her injected arm (left); Broke out in hives all over her body; "knocked up" for the first couple of days; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jul-2021 and was forwarded to Moderna on 20-Jul-2021.    This spontaneous case was reported by a health care professional and describes the occurrence of URTICARIA (Broke out in hives all over her body), VACCINATION SITE WARMTH (Left arm warm to the touch), VACCINATION COMPLICATION ("knocked up" for the first couple of days) and VACCINATION SITE SWELLING (Little golf ball appeared in her injected arm (left)) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051CZ1A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jun-2021, the patient experienced VACCINATION COMPLICATION ("knocked up" for the first couple of days). On 19-Jun-2021, the patient experienced URTICARIA (Broke out in hives all over her body). On 27-Jun-2021, the patient experienced VACCINATION SITE WARMTH (Left arm warm to the touch) and VACCINATION SITE SWELLING (Little golf ball appeared in her injected arm (left)). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) from 19-Jun-2021 to 22-Jun-2021 for Hives, at an unspecified dose and frequency. In June 2021, VACCINATION COMPLICATION ("knocked up" for the first couple of days) had resolved. On 22-Jun-2021, URTICARIA (Broke out in hives all over her body) had resolved. In July 2021, VACCINATION SITE WARMTH (Left arm warm to the touch) and VACCINATION SITE SWELLING (Little golf ball appeared in her injected arm (left)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. Patient received second dose of vaccination on 17Jul2021 - Lot number: 051C21A
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Asthenia, COVID-19, Headache
Clinical narrative: Loss of smell; Headache; I got tested and being positive with covid19; My symptom was sore throat; Loss of taste; No strength; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jul-2021. The most recent information was received on 29-Jul-2021 and was forwarded to Moderna on 29-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I got tested and being positive with covid19), OROPHARYNGEAL PAIN (My symptom was sore throat), AGEUSIA (Loss of taste), ASTHENIA (No strength) and ANOSMIA (Loss of smell) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sore throat from 17-Jul-2021 to 21-Jul-2021.   On 20-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Jul-2021, the patient experienced COVID-19 (I got tested and being positive with covid19), OROPHARYNGEAL PAIN (My symptom was sore throat), AGEUSIA (Loss of taste), ASTHENIA (No strength) and HEADACHE (Headache). On an unknown date, the patient experienced ANOSMIA (Loss of smell). The patient was treated with AMOXICILLIN (oral) for Sore throat, at a dose of 875 mg twice a day and PREDNISOLONE (oral) for Sore throat, at a dose of 15 ml once a day. At the time of the report, COVID-19 (I got tested and being positive with covid19), OROPHARYNGEAL PAIN (My symptom was sore throat) and HEADACHE (Headache) outcome was unknown and AGEUSIA (Loss of taste), ASTHENIA (No strength) and ANOSMIA (Loss of smell) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jul-2021, SARS-CoV-2 test: positive (Positive) Positive.         No Concomitant medications were reported.   This case was linked to MOD-2021-261824 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Follow-up information received on 29-JUL-2021 contains significant information .Patient  demographics updated. Patient history (sore throat) added. Treatment medications Added. Event (loss of smell) added.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, SARS-CoV-2 test
Clinical narrative: Loss of smell; Headache; I got tested and being positive with covid19; My symptom was sore throat; Loss of taste; No strength; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jul-2021. The most recent information was received on 29-Jul-2021 and was forwarded to Moderna on 29-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I got tested and being positive with covid19), OROPHARYNGEAL PAIN (My symptom was sore throat), AGEUSIA (Loss of taste), ASTHENIA (No strength) and ANOSMIA (Loss of smell) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sore throat from 17-Jul-2021 to 21-Jul-2021.   On 20-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Jul-2021, the patient experienced COVID-19 (I got tested and being positive with covid19), OROPHARYNGEAL PAIN (My symptom was sore throat), AGEUSIA (Loss of taste), ASTHENIA (No strength) and HEADACHE (Headache). On an unknown date, the patient experienced ANOSMIA (Loss of smell). The patient was treated with AMOXICILLIN (oral) for Sore throat, at a dose of 875 mg twice a day and PREDNISOLONE (oral) for Sore throat, at a dose of 15 ml once a day. At the time of the report, COVID-19 (I got tested and being positive with covid19), OROPHARYNGEAL PAIN (My symptom was sore throat) and HEADACHE (Headache) outcome was unknown and AGEUSIA (Loss of taste), ASTHENIA (No strength) and ANOSMIA (Loss of smell) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jul-2021, SARS-CoV-2 test: positive (Positive) Positive.         No Concomitant medications were reported.   This case was linked to MOD-2021-261824 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Follow-up information received on 29-JUL-2021 contains significant information .Patient  demographics updated. Patient history (sore throat) added. Treatment medications Added. Event (loss of smell) added.